Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Revenue

Novolog (Pharm-Up 1966) had revenue of 465.71M ILS in the quarter ending September 30, 2024, with 10.68% growth. This brings the company's revenue in the last twelve months to 1.73B, up 5.99% year-over-year. In the year 2023, Novolog (Pharm-Up 1966) had annual revenue of 1.64B with 8.99% growth.

• Revenue (ttm): 1.73B
• Revenue Growth: +5.99%
• P/S Ratio: 0.56
• Revenue / Employee: 1.81M
• Employees: 955
• Market Cap: 973.94M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.64B	135.54M	8.99%
Dec 31, 2022	1.51B	252.70M	20.13%
Dec 31, 2021	1.26B	121.61M	10.73%
Dec 31, 2020	1.13B	129.51M	12.90%
Dec 31, 2019	1.00B	94.17M	10.35%